INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Gene therapies been re-branded 'advanced therapies'—the feeding frenzy continues

Gene therapies been re-branded 'advanced therapies'—the feeding frenzy continues

Even FDAs top vaccine guy, Peter Marks, is in on it!

Hedley Rees's avatar
Hedley Rees
Nov 08, 2024
∙ Paid
16

Share this post

INSIDE PHARMA
INSIDE PHARMA
Gene therapies been re-branded 'advanced therapies'—the feeding frenzy continues
3
5
Share

[Note: this is a recycle from Jun 21, 2024]

Keep getting this advanced therapy conference in my mailbox

Every few weeks, I get an email from Terrapinn, asking me to buy a ticket for their 2024 conference on advanced therapies. The speaker list is below:

Advanced Therapies 2024, 19-20th March, ExCeL London

[Note: the link now refers to the 2025 conference and Peter Marks below is not featured. However, I’m sure the conference producers will confirm his attendance from 2020 - 2024]

Scroll down to speakers with the name beginning with ‘M’, and you will see Peter Marks M.D., PhD., Director - Center for Biologics Evaluation and Research (CBER) .

Marks is the person with delegated authority to evaluate and research applications to market new biologics drugs, eg vaccines.

Could this just be a teeny weeny conflict of interest?

Not at all, it’s a massive one!!!

It is also unprecedented for someone in his position to do anything other than fly-in for a Keynote Address, then fly out again. Hob nobbing …

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share